A n increasing body of evidence suggests that apoptosis plays an important role in cardiac development and diseases. This is based on the observation that in animals and humans, the ontogenesis of the normal heart is characterized by the appearance of apoptosis, which peaks in the perinatal period 1 and in specific regions of the heart. 2 Furthermore, myocardial infarction is associated with apoptosis in rats 3 and humans. 4 Additionally, apoptosis is evident in the hearts of patients suffering from certain conductance disturbances 2 ; it is also evident in various human cardiomyopathies, including arrhythmogenic right ventricular dysplasia 5 and dilated cardiomyopathy. 6 These studies providing proof of apoptotic cell death in the heart are also important because they show us that the capacity for apoptotic cell death exists in both mitotic cells and in postmitotic cells. However, little information exists regarding the identification of stimuli responsible for the induction of apoptosis in the heart. Interestingly, apoptosis occurs during reperfusion after ischemia in several organs, including the heart. 7 However, it is not known how reperfusion triggers apoptosis. Experimental studies using isolated organ preparations or in vivo animal models have demonstrated the generation of reactive oxygen species (ROS) during ischemia and reperfusion. 8 Also, several clinical procedures are frequently associated with ischemia and reperfusion injury on one side and production and release of ROS on the other, including clinical bypass surgery, 9 thrombosis, 10 and coronary balloon angioplasty. 11 That represents a ROS threat, even for the ontogenesis of the normal heart, was demonstrated recently by the induction of cardiomyopathies and early lethality in knockout mice lacking the manganese superoxide dismutase (SOD), which acts as an intracellular ROS-scavenger. 12 However, in all these cases, it remains unclear how ROS induce the pathological phenotype.
We used a cell culture model of isolated cardiac cells and different ROS-generating systems to determine whether ROS are able to induce apoptosis in cardiomyocytes, to evaluate the expression patterns of apoptosis-related genes, and to explore the apoptotic pathways in cardiomyocytes exposed to ROS.
Methods

Cell Cultures
Monolayer cultures of neonatal rat cardiac cells were prepared by modifying the method of Simpson et al. 13 Briefly, hearts from 1-day-old Wistar rats were dissected, minced, and placed in PBS. The tissue was trypsinized at 37°C in a HEPES-buffered saline solution ([in mmol/L] HEPES-NaOH 20 [pH 7.6], NaCl 130, KCl 3, NaH 2 PO 4 1, and glucose 4 and 0.15% trypsin). After centrifugation, cells were resuspended in Dulbecco's modified Eagle medium/F-12 (Gibco) containing 5% heat-inactivated horse serum, 100 mol/L ascorbate, 1 g/mL insulin, 1 g/mL transferrin, 10 ng/mL selenium, 100 U/mL penicillin, and 100 g/mL streptomycin. The dissociated cells were preplated at 37°C for 1 hour. The cells were then diluted to 1ϫ10 6 cells/mL, plated in 94-mm cultured dishes (for MTT assay, in 96-well plates) and, before use, were cultured for 62 to 72 hours in a medium containing 0.1 mmol/L bromodeoxyuridine to prevent proliferation of nonmyocytes. More than 95% of cells were cardiomyocytes, as detected by immunostaining with the ␣-sarcomeric actin antibody.
Exposure of Cells to ROS-Generating Systems
Cultured cells were washed twice with Hanks's balanced salt solution (HBSS) at 37°C. Washed cells were incubated at 37°C for 1 hour in HBSS containing the indicated concentration of xanthine oxidase plus xanthine (XO/X) or H 2 O 2 plus ferrous sulfate, as described elsewhere. 14 When superoxide dismutase (SOD), catalase (CAT), or 4,5-dihydroxy-1,3-benzene disulfonic acid (Tiron) were used (all from Sigma), they were added simultaneously with XO/X. To demonstrate the specificity of the effect of SOD and CAT, exposures with heat-inactivated SOD or CAT (100°C for 1 hour before addition) were also performed; all resulted in the complete abrogation of the effect of these enzymes on cell viability or protein expression in the presence of XO/X. Furthermore, incubation of cells with SOD or CAT in the absence of XO/X had no significant effect on cell viability, as detected by MTT and trypan blue exclusion, or protein expression, as detected by immunoblotting (data not shown). Z-VAD-fmk (Calbiochem) was used 2 hours before and immediately after treatment.
Cell Viability Assay, Cell-Death Detection ELISA, and In Situ Nick-End Labeling
These procedures were performed as described elsewhere. 14 
Immunoblot Analysis
Cells were lysed for 1 hour at 4°C in a lysis buffer ([in mmol/L] Tris 20 [pH 7.5], EDTA 2, EGTA 3, DTT 2, sucrose 250, and PMSF 0.1; 1% Triton X-100; and 10 g/mL each of leupeptin, aprotinin, and pepstatin A). Samples containing 50 g of protein were subjected to 12% SDS-PAGE and transferred to nitrocellulose membranes. Equal-protein loading was controlled by Ponceau red staining of membranes. Blots were probed using primary antibodies. These included polyclonal Bcl-2 antibody, polyclonal Bax antibody, cytochrome c monoclonal antibody (all from Pharmingen), p53 monoclonal antibody (Calbiochem), poly(ADP-ribose) polymerase (PARP) monoclonal antibody (Clontech), Bad monoclonal antibody (Transduction Laboratories), CPP32 polyclonal antibody, Mch2␣ polyclonal antibody, lamin A polyclonal antibody (all from Santa Cruz), and cytochrome oxidase (subunit II) monoclonal antibody (Molecular Probes). Blots were then probed by horseradish peroxidase-conjugated goat anti-rabbit IgG, rabbit anti-mouse IgG, or donkey anti-goat IgG (all from Amersham). Antigen-antibody complexes were visualized by enhanced chemiluminescence.
Preparation of Subcellular Fractions
Cells were washed twice with PBS, and the pellet was suspended in 0.5 mL of buffer ([in mmol/L] HEPES 20 [pH 7.5], KCl 10, MgCl 2 1.5, EGTA 1, EDTA 1, DTT 1, and PMSF 0.1, and 10 g/mL each of leupeptin, aprotinin, and pepstatin A) containing 250 mmol/L sucrose. The cells were homogenized by 5 strokes in a Dounce homogenizer. Subcellular fractions were prepared as described elsewhere. 15 In brief, the homogenates were centrifuged twice at 750g for 5 minutes at 4°C to collect nuclei and unbroken cells. The supernatants were centrifuged at 10 000g for 15 minutes at 4°C to collect the heavy-membrane pellet (HM). The resulting supernatants were centrifuged at 100 000g for 1 hour at 4°C to yield lightmembrane pellets (LM). The final supernatants were called cytosolic fractions. The samples were kept at Ϫ80°C. To verify the distribution of mitochondria and lysosomes in the subcellular fractions, we determined the activities of monoamine oxidase, a marker enzyme of mitochondria, and of acid phosphatase, a lysosomal marker enzyme. Monoamine oxidase activity was assayed using a method described previously. 16 The assay was performed at room temperature in a mixture containing 50 mmol/L Tris-HCl (pH 7.4), 0.22 mmol/L kynuramine, and 80 mol/L MgCl 2 . The reaction was stopped by adding 0.5 mol/L NaOH and 10% ZnSO 4 . The reaction product was determined by measuring the absorbance at 330 nm, and 4-hydroxyquinoline was used as the standard. The activity of acid phosphatase was detected as described elsewhere. 17 The assay was started by incubating the sample with 100 mmol/L acetic acidsodium acetate buffer (pH 4.5), which contained 4.5 mmol/L p-nitrophenyl phosphate and 0.05% Triton X-100. The assay was conducted at room temperature, and the reaction was stopped with 2 mol/L NaOH. The absorbance was measured at 405 nm. Monoamine oxidase activity represented 92.5Ϯ2.2% (nϭ3) of total enzyme activity in HM and 6.3Ϯ3.8% (nϭ3) in LM, whereas acid phosphatase activity was 24.7Ϯ8.5% (nϭ3) of total enzyme activity assessed in HM and 72.2Ϯ8.4% (nϭ3) in LM. These data indicate that the majority of mitochondria were in HM.
Immunoprecipitation
HM or LM was resuspended in a buffer (10 mmol/L HEPES [pH 7.4]; 38 mmol/L NaCl; 0.1 mmol/L PMSF; and 10 g/mL each of leupeptin, aprotinin, and pepstatin A); they were then homogenized in a Dounce homogenizer. To perform immunoprecipitations, the cytosol, HM, or LM lysates were precleared with 10% (vol/vol) protein A-agarose for 1 hour on a rocking platform. Specific antibodies were added and rocked for 1 hour. Immunoprecipitates were captured with 10% (vol/vol) protein A-agarose for another hour. The agarose beads were spun down and washed 3 times with NET buffer. The antigens were released and denatured by adding SDS sample buffer. Immunoblot analysis was performed as described above.
Statistical Analysis
All results are expressed as meanϮSEM of at least 3 independent experiments unless stated otherwise. Paired data were evaluated by Student's t test. A 1-way ANOVA was used for multiple comparisons. A value of PϽ0.05 was considered significant.
Results
ROS-Induced Death in Cardiac Cells
Exposure of isolated cardiac cells to H 2 O 2 led to a dosedependent decrease in cell viability, as assessed by MTT assay ( Figure 1A) . XO plus 0.1 mmol/L xanthine (XO/X) was used to generate superoxide anion (O 2 Ϫ ), and cell viability was assessed by trypan blue exclusion because XO/X itself may interfere with the MTT reaction. Again, a dosedependent decrease in cell viability could be observed ( Figure  1B) . However, because XO/X yields both O 2 Ϫ and H 2 O 2 , the ROS scavengers SOD, Tiron, and CAT were used to determine the contribution of each of these ROS in the XO/Xinduced death of cardiac cells ( Figure 1C ). In the presence of SOD, the effect of XO/X on cell viability was partially reversed, indicating that the generation of O 2 Ϫ contributed to XO/X-induced cell death; this finding was corroborated by replacing SOD with tiron, a cell membrane-permeable scavenger of O 2 Ϫ . The presence of CAT had a similar effect on cell viability as SOD. The combination of CAT with SOD or with Tiron resulted in the complete prevention of XO/Xinduced cell death. Taken together, these data suggest that H 2 O 2 or O 2 Ϫ or both are able to induce death in cardiac cells.
ROS-Induced Apoptosis in Cardiomyocytes
We hypothesized that exposure to ROS might lead to cell death through the induction of apoptosis in cardiac cells. As determined by cell-death detection ELISA, which specifically detects histone-associated DNA fragments within the cytoplasmic fraction of stimulated cells, there was a dosedependent increase of oligonucleosomes in the cytoplasmic fraction after H 2 O 2 treatment (Figure 2A) . Similar results were obtained in cells exposed to XO/X ( Figure 2B ). Administration of SOD, CAT, or Tiron attenuated the effect of XO/X, whereas the presence of SOD or Tiron in conjunction with CAT almost completely abrogated the effect of XO/X ( Figure 2C ). To determine whether apoptosis was occurring in cardiomyocytes compared with cardiac nonmyocytes (which are always present in cultures of neonatal rat cardiomyocytes), we used in situ nick-end labeling together with immunofluorescence ( Figure 2D) . The results show that in contrast to the control, apoptotic cardiomyocytes could be detected, simultaneously stained with ␣-sarcomeric actin and terminal deoxynucleotidyl transferase-mediated dUTP biotin nick-end labeling (TUNEL), when cultures were treated with 0.1 mmol/L H 2 O 2 . Similar results were obtained using 0.04 U/mL xanthine oxidase in the presence of 0.1 mmol/L xanthine plus CAT (500 U/mL). Taken together, these results suggest that H 2 O 2 , or O 2 Ϫ , or both are able to induce apoptosis in cardiomyocytes.
Effect of ROS on the Expression of Apoptosis-Related Factors
The induction of apoptosis is associated with the expression and/or activation of specific proteins, resulting in the execution of the apoptotic program within the affected cells. In general, a plethora of different signaling pathways could be involved in apoptosis, depending on the stimulus and/or type of cells affected. To specify the signaling pathway in ROS-induced apoptosis in cardiomyocytes, we first determined the protein levels of well-known apoptosis-related factors such as Bcl-2, Bax, Bad, and p53 ( Figure 3 Figure 4A ). To exclude the possibility of a significant contamination of our cytosolic fraction with mitochondria, we reprobed our blots with an antibody directed against mitochondrial cytochrome oxidase ( Figure 4A ). Cytochrome oxidase was nearly undetectable throughout the investigated time interval. Release of cytochrome c may lead to the activation of CPP32, which can be detected by its cleavage from the inactive pro-CPP32 to the active 17-kDa product, as we observed 3 hours after exposure to H 2 O 2 ( Figure 4A) . A 85-kDa fragment of PARP, also indicating CPP32 activation, became visible 3 hours after H 2 O 2 treatment ( Figure 4A ). These data indicate that mitochondrial release of cytochrome c, with subsequent activation of caspase CPP32, is involved in H 2 O 2 -induced cardiomyocyte apoptosis.
Intriguingly, O 2 Ϫ -induced cardiomyocyte apoptosis was not accompanied by the release of cytochrome c, activation of CPP32, or cleavage of PARP ( Figure 4B ). However, Z-VAD-fmk, a pan-caspase inhibitor, could significantly inhibit O 2 Ϫ -induced histone-associated DNA fragmentation ( Figure 5A ). This indicates that O 2 Ϫ uses caspase pathways other than CPP32 to induce apoptosis in cardiomyocytes. Using anti-Mch2␣ antibody revealed that Mch2␣ was activated, as indicated by the formation of p20 (the active form of Mch2␣) 2 hours after the stimulation of cardiomyocytes with XO/X plus CAT ( Figure 5B ). At the same time point, lamin A, which is a substrate of Mch2␣, 18, 19 was cleaved into a 46-kDa fragment in cardiomyocytes treated with XO/X plus CAT ( Figure 5C ). Z-VAD-fmk could inhibit Mch2␣ processing, thereby 
H 2 O 2 Induces Translocation of Bax and Bad from Cytosol to Mitochondria and Their Interaction With Bcl-2
To identify the factors responsible for controlling cytochrome c release in cardiomyocytes, we prepared subcellular fractions before and after treatment with H 2 O 2 ; these fractions -induced Mch2␣ activation in cardiomyocytes. Cells were exposed to 0.04 U XO/mL plus 0.1 mmol/L xanthine in presence of 500 U/mL, as described in Figure 1 . A, DNA fragmentation was assessed by cell-death ELISA. Z-VAD-fmk was added at indicated doses 2 hours before and immediately after treatment. *PϽ0.05 compared with XO/XϩCAT alone. B, Immunoblot analysis of Mch2␣ and its active form p20 and (C) of lamin A and its cleavage product p46; Tiron was at 1 mmol/L and Z-VAD-fmk was at 50 mol/L. Representative blots of at least 3 independent experiments are shown.
included cytosol, mitochondria-enriched HM, or LM. Bad, Bax, and Bcl-2, all of which are involved in the regulation of cytochrome c release from mitochondria in apoptosis, were immunoprecipitated by their antibodies and then subjected to SDS-PAGE for immunoblot detection. Before H 2 O 2 treatment, Bad and Bax were found predominantly in the cytosolic fractions, with only faint signals in mitochondria-enriched HM, and they were undetectable in LM. At 1 hour after H 2 O 2 treatment, both Bad and Bax translocated from the cytosol to HM but not to LM. Before and after H 2 O 2 treatment, Bcl-2 could be observed only in HM but not in the cytosolic or LM fractions ( Figure 6A) . In contrast to H 2 O 2 , O 2 Ϫ did not change the subcellular localization patterns of Bad, Bax, or Bcl-2 (data not shown).
To determine whether the translocation of Bad and Bax to the mitochondria involves the interaction of these 2 factors with Bcl-2 (a factor that inhibits apoptosis by preventing cytochrome c release 15, 20 ), immunoprecipitates of Bad or Bax were blotted against an anti-Bcl-2 antibody. Both Bad and Bax appeared in Bcl-2 complexes in cardiomyocytes 1 hour after stimulation with H 2 O 2 ( Figure 6B ). As expected, no dimerization could be observed in cardiomyocytes stimulated by O 2 Ϫ (data not shown). These data indicate that cytochrome c release in cardiomyocytes exposed to H 2 O 2 is paralleled by the translocation of Bad and Bax from the cytosol to the mitochondria, in which they form heterodimers with the antiapoptotic Bcl-2, suggesting a functional role of these 2 factors in apoptosisrelated cytochrome c release. The lack of their translocation to the mitochondria in O 2 Ϫ -induced apoptosis may explain why we could not observe cytochrome c release in O 2 Ϫ -stimulated cardiomyocytes.
Discussion
Growing evidence shows that ROS play an important role in the pathogenesis of a variety of cardiac diseases. However, little information exists about the mechanisms by which ROS elicit their effect on the structure and function of the heart. The present work reveals that ROS induce apoptosis in cardiomyocytes and that different ROS may use distinct apoptotic pathways.
Several lines of evidence indicate a tight interrelationship between p53 and oxidative stress. Conformation and DNA binding activity of p53 are modulated by intracellular redox potential. 21 Furthermore, a potent transactivator of p53 is Ref-1, a redox/repair protein. 22 Additionally, overexpression of p53 leads to the transactivation of gene-encoding proteins that are able to respond to oxidative stress. 23 sites and encodes an apoptosis-inducing factor. 24 Strikingly, in both instances, p53 upregulation was not followed by the induction of Bax expression. Two possible explanations exist for this observation. First, although its expression is increased, p53 may not be functionally active in our model. This possibility is supported by a study that demonstrated p53-independent activation of p21 WAF1/CIP1 by oxidative stress. 25 Second, p53 may induce apoptosis independent of the transactivation of Bax, a possibility that has been observed in other cell-culture systems. 26 Bcl-2, a well-known antiapoptotic factor, inhibited apoptosis in rat cardiomyocytes overexpressing p53. 27 Neither H 2 O 2 nor O 2 Ϫ induced significant changes in Bcl-2 expression. To determine the functional activity of the Bcl-2 family members, we investigated the release of cytochrome c, which is tightly regulated by the equilibrium between antiapoptotic Bcl-2 and proapoptotic Bad and Bax. 15, 20 Cytochrome c participates in the execution of apoptosis. 28, 29 Our data show that cytochrome c is released in H 2 O 2 -induced cardiomyocyte apoptosis, implying a predominant activity of proapoptotic members of the Bcl-2 family. Therefore, we detected the subcellular distribution of Bax and Bad, which we found migrated from the cytosol to mitochondria. This led us to speculate that they may form heterodimers with Bcl-2 to counteract its antiapoptotic function. This assumption was confirmed by the appearance of Bad and Bax in Bcl-2 complexes in cardiomyocytes exposed to H 2 O 2 . Thus, the redistribution of Bad and Bax and their interactions with Bcl-2 may play an important role in regulating cytochrome c release, which subsequently leads to the activation of CPP32 and cleavage of PARP. This indicates the existence of cytochrome c-related apoptotic pathways in cardiomyocytes. However, as observed in the present study, O 2 Ϫ -induced apoptosis was not accompanied by cytochrome c release, suggesting that there also are other cytochrome c-independent pathways of apoptosis in cardiomyocytes. O 2 Ϫ uses a pathway that includes Mch2␣ activation. The precise substrate specificity of different caspase family members is not yet clear. Mch2␣ is the only known laminase. 18, 19 It also can cleave PARP in vitro, but such an activity occurs infrequently. 18 This may explain why the activation of Mch2␣ is not accompanied by PARP cleavage in our present study.
Apoptosis occurs in the heart during processes associated with the production and release of ROS, including ischemia and reperfusion. 7 However, until now, only a few factors could be identified that triggered apoptosis in the heart during these and other processes. Our data provide the first link between pathophysiological events resulting in the production of ROS on one side, and the induction of apoptosis in cardiomyocytes on the other.
ROS elicit an array of damages to the cell, including membrane lipid peroxidation, cross-linking and degradation of proteins, and the nicking of DNA, resulting in the impairment of cellular integrity and function. Thus, one might speculate that the induction of apoptosis in cardiomyocytes exposed to ROS represents an evolutionarily-conserved protective mechanism of disposing of those cells that do not conform and function properly and, thus, might put cardiac function and integrity at risk.
In summary, our study identified ROS as potential inducers of cardiomyocyte apoptosis. H 2 O 2 and O 2 Ϫ trigger distinct apoptotic signaling pathways in cardiomyocytes, including the release of cytochrome c and the activation of CPP32 by H 2 O 2 and Mch2␣ activation by O 2 Ϫ . Future studies are needed to determine whether the cytochrome c/CPP32 signaling pathway is triggered by other apoptotic stimuli in the heart and whether the specific inhibition of this pathway prevents cardiomyocyte apoptosis in vivo.
